drugset / Trial / NCT01359787
Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).
Timeline
- Start
- 2011-05
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mapracorat | Small molecule | 0.01 % | Topical |
| Comparator | Mapracorat | Small molecule | 0.03 % | Topical |
| Comparator | Mapracorat | Small molecule | 0.1 % | Topical |